Graham Capital Management »

4d Molecular Therapeutics In shares owned by Graham Capital Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $214k 20k 10.81
2024-06-30 $308k 15k 20.99

More positions owned by Graham Capital Management

Microstrategy Cl A New Put Option (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Microstrategy Note 2/1 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Vaneck Etf Trust Junior Gold Mine Call Option (GDXJ)
Tilray Brands Note 5.200% 6/1 (Principal)
Novavax Note 5.000%12/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Penn Entertainment Note 2.750% 5/1 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)

View all positions for Graham Capital Management

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
BlackRock
BlackRock
VR Adviser
Goldman Sachs Group
Deep Track Capital
Henderson Group
Vanguard Group
State Street Corporation
Assenagon Asset Management
Novo A/S
Morgan Stanley
Redmile Group
Braidwell

View all funds holding 4d Molecular Therapeutics In